The Janus face of HIF-1α in ischemic stroke and the possible associated pathways
Nashwa Amin,Irum Naz Abbasi,Fei Wu,Zongjie Shi,Javaria Sundus,Azhar Badry,Xia Yuan,Bing-Xin Zhao,Jie Pan,Xiao-Dan Mi,Yuhuan Luo,Yu Geng,Marong Fang
DOI: https://doi.org/10.1016/j.neuint.2024.105747
IF: 4.297
2024-04-24
Neurochemistry International
Abstract:Stroke is the most devastating disease, causing paralysis and eventually death. Many clinical and experimental trials have been done in search of a new safe and efficient medicine; nevertheless, scientists have yet to discover successful remedies that are also free of adverse effects. This is owing to the variability in intensity, localization, medication routes, and each patient's immune system reaction. HIF-1α represents the modern tool employed to treat stroke diseases due to its functions: downstream genes such as glucose metabolism, angiogenesis, erythropoiesis, and cell survival. Its role can be achieved via two downstream EPO and VEGF strongly related to apoptosis and antioxidant processes. Recently, scientists paid more attention to drugs dealing with the HIF-1 pathway. This review focuses on medicines used for ischemia treatment and their potential HIF-1α pathways. Furthermore, we discussed the interaction between HIF-1 and other biological pathways such as oxidative stress; however, a spotlight has been focused on certain potential signaling contributed to the HIF-1 pathway. HIF-1 is an essential regulator of oxygen balance within cells which affects and controls the expression of thousands of genes related to sustaining homeostasis as oxygen levels fluctuate. HIF-1α's role in ischemic stroke strongly depends on the duration and severity of brain damage after onset. HIF-1 remains difficult to investigate, particularly in ischemic stroke, due to alterations in the acute and chronic phases of the disease, as well as discrepancies between the penumbra and ischemic core. This review emphasizes these contrasts and analyzes the future of this intriguing and demanding field.
biochemistry & molecular biology,neurosciences